Bremelanotide, is a synthetic peptide and is a medication used to treat hypoactive sexual desire disorder (HSDD) in women. HSDD is characterized by a persistent lack of sexual desire that causes distress. Bremelanotide works by activating melanocortin receptors in the brain, leading to increased sexual desire and arousal.
The medication Tadalafil, the active ingredient in Cialis, is FDA approved for the treatment of erectile dysfunction – It may increase blood flow to the genital area, potentially enhancing sexual arousal and pleasure.
Oxytocin, often referred to as the “love drug,” is a hormone released during intimate moments and social connections. It promotes feelings of trust, empathy, and attachment, enhancing the emotional bond between individuals and playing a role in fostering love, affection, and emotional intimacy.
Enhances Sexual Desire: Bremelanotide is effective in increasing libido by activating neural pathways related to sexual desire in the brain. This makes it a powerful option for premenopausal women looking to enhance their sexual motivation and experiences.
Convenient, As-Needed Use: The medication is administered via a subcutaneous injection and is used only when needed, rather than on a daily schedule. This flexibility allows women to use the medication specifically in anticipation of sexual activity, offering control and convenience.
Non-Hormonal Treatment: Bremelanotide does not affect hormone levels, which is a crucial benefit for women who prefer not to use hormonal therapies or have health conditions that preclude such treatments. This feature helps avoid the side effects associated with hormonal adjustments.